Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Necrosis"" wg kryterium: Temat


Starter badań:

Tytuł :
Erythematous plaques with zosteriform distribution in a patient treated with TNF-α inhibitor adalimumab for psoriasis.
Autorzy :
Garcia-Melendo C; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Cubiró X; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Tubau C; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Mozos A; Department of Pathology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Muñoz C; Department of Microbiology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Puig L; Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Pokaż więcej
Źródło :
International journal of dermatology [Int J Dermatol] 2021 Nov; Vol. 60 (11), pp. 1366-1367. Date of Electronic Publication: 2021 Jun 17.
Typ publikacji :
Journal Article
MeSH Terms :
Psoriasis*/drug therapy
Tumor Necrosis Factor-alpha*
Adalimumab/adverse effects ; Etanercept ; Humans ; Infliximab ; Tumor Necrosis Factor Inhibitors
Czasopismo naukowe
Tytuł :
Orbital fat necrosis following a revision endoscopic dacryocystorhinostomy.
Autorzy :
Galindo-Ferreiro A; Department of Ophthalmology, Rio Hortega University Hospital, Valladolid, Spain.
Torres Nieto MA; Department of Pathology, Rio Hortega University Hospital, Valladolid, Spain.
Ali MJ; Govindram Seksaria Institute of Dacryology, L.V. Prasad Eye Institute, Hyderabad, India.
Pokaż więcej
Źródło :
European journal of ophthalmology [Eur J Ophthalmol] 2021 Nov; Vol. 31 (6), pp. NP18-NP21. Date of Electronic Publication: 2020 Jun 03.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Dacryocystorhinostomy*
Fat Necrosis*
Adipose Tissue ; Female ; Humans ; Middle Aged ; Necrosis/etiology ; Orbit
Czasopismo naukowe
Tytuł :
Inflammatory Molecules Released by Mechanically Injured Astrocytes Trigger Presynaptic Loss in Cortical Neuronal Networks.
Autorzy :
Lantoine J; Mechanobiology & Soft Matter Group, Interfaces and Complex Fluids Laboratory, Research Institute for Biosciences, University of Mons, 7000 Mons, Belgium.
Procès A; Mechanobiology & Soft Matter Group, Interfaces and Complex Fluids Laboratory, Research Institute for Biosciences, University of Mons, 7000 Mons, Belgium.; Laboratory of Neuroscience, Research Institute for Biosciences, Faculty of Medicine and Pharmacy, University of Mons, 7000 Mons, Belgium.
Villers A; Laboratory of Neuroscience, Research Institute for Biosciences, Faculty of Medicine and Pharmacy, University of Mons, 7000 Mons, Belgium.
Halliez S; Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, LabEx DISTALZ, F-59000 Lille, France.
Buée L; Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, LabEx DISTALZ, F-59000 Lille, France.
Ris L; Laboratory of Neuroscience, Research Institute for Biosciences, Faculty of Medicine and Pharmacy, University of Mons, 7000 Mons, Belgium.
Gabriele S; Mechanobiology & Soft Matter Group, Interfaces and Complex Fluids Laboratory, Research Institute for Biosciences, University of Mons, 7000 Mons, Belgium.
Pokaż więcej
Źródło :
ACS chemical neuroscience [ACS Chem Neurosci] 2021 Oct 20; Vol. 12 (20), pp. 3885-3897. Date of Electronic Publication: 2021 Oct 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Astrocytes*
Receptors, Tumor Necrosis Factor, Type II*
Cells, Cultured ; Cytokines ; Humans ; Tumor Necrosis Factor-alpha
Czasopismo naukowe
Tytuł :
Use of Tumor Necrosis Factor Inhibitors During the COVID-19 Pandemic-Evidence in Favor of Monotherapy.
Autorzy :
Velloso LA; Department of Internal Medicine, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil.
Pokaż więcej
Źródło :
JAMA network open [JAMA Netw Open] 2021 Oct 01; Vol. 4 (10), pp. e2129707. Date of Electronic Publication: 2021 Oct 01.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
COVID-19*
Tumor Necrosis Factor Inhibitors*
Humans ; Pandemics ; SARS-CoV-2 ; Tumor Necrosis Factor-alpha
Czasopismo naukowe
Tytuł :
Higher adalimumab maintenance regimen is more effective than standard dose in anti-TNF experienced Crohn's disease patients.
Autorzy :
Greener T; Digestive Disease Institute, Sha'are Zedek Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
Boland K; Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital IBD Centre, Ontario.; Division of Gastroenterology, Department of Medicine, University of Toronto, Toronto, Canada.
Milgrom R; Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital IBD Centre, Ontario.; Division of Gastroenterology, Department of Medicine, University of Toronto, Toronto, Canada.
Ben-Bassat O; Department of Gastroenterology, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Steinhart AH; Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital IBD Centre, Ontario.; Division of Gastroenterology, Department of Medicine, University of Toronto, Toronto, Canada.
Silverberg MS; Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital IBD Centre, Ontario.; Division of Gastroenterology, Department of Medicine, University of Toronto, Toronto, Canada.
Narula N; Division of Gastroenterology, Department of Medicine, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
Pokaż więcej
Źródło :
European journal of gastroenterology & hepatology [Eur J Gastroenterol Hepatol] 2021 Oct 01; Vol. 33 (10), pp. 1274-1279.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Crohn Disease*/diagnosis
Crohn Disease*/drug therapy
Tumor Necrosis Factor Inhibitors*
Adalimumab/adverse effects ; Humans ; Infliximab ; Retrospective Studies ; Treatment Outcome ; Tumor Necrosis Factor-alpha
Czasopismo naukowe
Tytuł :
Subcutaneous fat necrosis of the newborn presenting as circular alopecia: a novel presentation.
Autorzy :
Xu Z; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Rubin AI; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Section of Pediatric Dermatology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Oboite M; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Section of Pediatric Dermatology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Pokaż więcej
Źródło :
Pediatric dermatology [Pediatr Dermatol] 2021 Jul; Vol. 38 (4), pp. 982-983. Date of Electronic Publication: 2021 Jun 18.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Fat Necrosis*/complications
Fat Necrosis*/diagnosis
Hypercalcemia*
Alopecia/diagnosis ; Alopecia/etiology ; Female ; Humans ; Infant ; Infant, Newborn ; Necrosis ; Subcutaneous Fat
Czasopismo naukowe
Tytuł :
MLKL and CaMKII Are Involved in RIPK3-Mediated Smooth Muscle Cell Necroptosis.
Autorzy :
Zhou T; Department of Surgery, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.
DeRoo E; Department of Surgery, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.
Yang H; Department of Surgery, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.
Stranz A; Department of Surgery, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.
Wang Q; Department of Surgery, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.
Ginnan R; Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY 12208, USA.
Singer HA; Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY 12208, USA.
Liu B; Department of Surgery, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.; Department of Cellular and Regenerative Biology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.
Pokaż więcej
Źródło :
Cells [Cells] 2021 Sep 12; Vol. 10 (9). Date of Electronic Publication: 2021 Sep 12.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Necrosis*
Aortic Aneurysm, Abdominal/*pathology
Calcium-Calmodulin-Dependent Protein Kinase Type 2/*metabolism
Myocytes, Smooth Muscle/*pathology
Protein Kinases/*metabolism
Receptor-Interacting Protein Serine-Threonine Kinases/*physiology
Animals ; Aortic Aneurysm, Abdominal/chemically induced ; Aortic Aneurysm, Abdominal/metabolism ; Calcium Chloride/toxicity ; Calcium-Calmodulin-Dependent Protein Kinase Type 2/antagonists & inhibitors ; Calcium-Calmodulin-Dependent Protein Kinase Type 2/genetics ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Myocytes, Smooth Muscle/metabolism ; Phosphorylation ; Protein Kinases/chemistry ; Protein Kinases/genetics ; RNA, Small Interfering/genetics ; Signal Transduction ; Tumor Necrosis Factor-alpha/metabolism
Czasopismo naukowe
Tytuł :
Evaluation of factors affecting the frequency and clinical course of COVID-19 in patients using anti-TNF-alpha agents.
Autorzy :
Baslılar S; Umraniye Training and Research Hospital, Department of Pulmonology - Istanbul, Turkey.
Pehlivan O; Umraniye Training and Research Hospital, Department of Rheumatology - Istanbul, Turkey.
Pokaż więcej
Źródło :
Revista da Associacao Medica Brasileira (1992) [Rev Assoc Med Bras (1992)] 2021 Sep; Vol. 67 (9), pp. 1286-1292.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
Tumor Necrosis Factor Inhibitors*
Adult ; Female ; Hospitalization ; Humans ; Male ; Middle Aged ; Retrospective Studies ; SARS-CoV-2 ; Tumor Necrosis Factor-alpha
Czasopismo naukowe
Tytuł :
Editorial: does anti-TNF 'treatment persistence' always equate to 'effective treatment'? Only objective disease assessments can answer the question. Authors' reply.
Autorzy :
Blesl A; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Högenauer C; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.; Biotechmed, Graz, Austria.
Borenich A; Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.
Berghold A; Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.
Wenzl H; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Petritsch W; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Sep; Vol. 54 (5), pp. 720-721.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Inflammatory Bowel Diseases*
Tumor Necrosis Factor Inhibitors*
Humans ; Treatment Outcome ; Tumor Necrosis Factor-alpha
Opinia redakcyjna
Tytuł :
[Placental transfer of monoclonal antibodies: The example of anti-TNF alpha drugs].
Autorzy :
Beghin D; Centre de référence sur les agents tératogènes (CRAT), DMU Épidémiologie et biostatistique, Santé publique, Pharmacie, Pharmacologie, Recherche, Information médicale, Thérapeutique et médicaments (ESPRIT), GHU, AP-HP, Sorbonne université - site Trousseau, 26, avenue Dr-Netter, 75571 Paris cedex 12, France. Electronic address: .
Pokaż więcej
Transliterated Title :
Le passage placentaire des anticorps monoclonaux : exemple des anti-TNF alpha.
Źródło :
Gynecologie, obstetrique, fertilite & senologie [Gynecol Obstet Fertil Senol] 2021 Sep; Vol. 49 (9), pp. 724-726. Date of Electronic Publication: 2021 Jun 29.
Typ publikacji :
Journal Article
MeSH Terms :
Pharmaceutical Preparations*
Tumor Necrosis Factor Inhibitors*
Antibodies, Monoclonal ; Female ; Humans ; Placenta ; Pregnancy ; Tumor Necrosis Factor-alpha
Czasopismo naukowe
Tytuł :
Risk factors for dermatological complications of anti-TNF therapy in a cohort of children with Crohn's disease.
Autorzy :
Hradsky O; Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 150 06, Prague 5, Prague, Czech Republic. .
Kazeka D; Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 150 06, Prague 5, Prague, Czech Republic.
Copova I; Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 150 06, Prague 5, Prague, Czech Republic.
Lerchova T; Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 150 06, Prague 5, Prague, Czech Republic.
Mitrova K; Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 150 06, Prague 5, Prague, Czech Republic.
Pospisilova K; Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 150 06, Prague 5, Prague, Czech Republic.
Sulovcova M; Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 150 06, Prague 5, Prague, Czech Republic.
Zarubova K; Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 150 06, Prague 5, Prague, Czech Republic.
Bronsky J; Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, 150 06, Prague 5, Prague, Czech Republic.
Pokaż więcej
Źródło :
European journal of pediatrics [Eur J Pediatr] 2021 Sep; Vol. 180 (9), pp. 3001-3008. Date of Electronic Publication: 2021 Apr 19.
Typ publikacji :
Journal Article
MeSH Terms :
Crohn Disease*/complications
Crohn Disease*/drug therapy
Tumor Necrosis Factor Inhibitors*
Child ; Humans ; Infliximab/adverse effects ; Retrospective Studies ; Risk Factors ; Treatment Outcome ; Tumor Necrosis Factor-alpha
Czasopismo naukowe
Tytuł :
Paradoxical psoriasis induced by anti-TNF-alpha successfully treated with brodalumab.
Autorzy :
Cortonesi G; Dermatology Section, Department of Medical, Surgical and Neurological Sciences, Santa Maria Alle Scotte Hospital, Siena, Italy.
Trovato E; Dermatology Section, Department of Medical, Surgical and Neurological Sciences, Santa Maria Alle Scotte Hospital, Siena, Italy.
Orsini C; Dermatology Section, Department of Medical, Surgical and Neurological Sciences, Santa Maria Alle Scotte Hospital, Siena, Italy.
Cinotti E; Dermatology Section, Department of Medical, Surgical and Neurological Sciences, Santa Maria Alle Scotte Hospital, Siena, Italy.
Rubegni P; Dermatology Section, Department of Medical, Surgical and Neurological Sciences, Santa Maria Alle Scotte Hospital, Siena, Italy.
Pokaż więcej
Źródło :
Dermatologic therapy [Dermatol Ther] 2021 Sep; Vol. 34 (5), pp. e15084. Date of Electronic Publication: 2021 Aug 10.
Typ publikacji :
Letter
MeSH Terms :
Psoriasis*/chemically induced
Psoriasis*/diagnosis
Psoriasis*/drug therapy
Tumor Necrosis Factor Inhibitors*
Antibodies, Monoclonal, Humanized ; Humans ; Tumor Necrosis Factor-alpha
Opinia redakcyjna
Tytuł :
Cost-Effectiveness Analysis of Vedolizumab Compared With Infliximab in Anti-TNF-α-Naïve Patients With Moderate-to-Severe Ulcerative Colitis in China.
Autorzy :
Zhou T; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Sheng Y; Medical Affairs, Takeda (China) International Trading Company, Beijing, China.
Guan H; Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China Center for Health Economic Research, Peking University, Beijing, China.
Meng R; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Wang Z; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Pokaż więcej
Źródło :
Frontiers in public health [Front Public Health] 2021 Aug 20; Vol. 9, pp. 704889. Date of Electronic Publication: 2021 Aug 20 (Print Publication: 2021).
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms :
Colitis, Ulcerative*/drug therapy
Tumor Necrosis Factor Inhibitors*
Adult ; Antibodies, Monoclonal, Humanized ; China ; Cost-Benefit Analysis ; Humans ; Infliximab/therapeutic use ; Tumor Necrosis Factor-alpha
Czasopismo naukowe
Tytuł :
Editorial: withdrawal of anti TNF-alpha - are we ready for biological therapy cycling?
Autorzy :
Pugliese D; CEMAD, IBD UNIT, Unità Operativa Complessa di Medicina Interna e Gastroenterologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.
Armuzzi A; CEMAD, IBD UNIT, Unità Operativa Complessa di Medicina Interna e Gastroenterologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.; Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (1), pp. 84-85.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Inflammatory Bowel Diseases*
Tumor Necrosis Factor Inhibitors*
Biological Therapy ; Humans ; Infliximab ; Tumor Necrosis Factor-alpha
Opinia redakcyjna
Tytuł :
A wake-like state in vitro induced by transmembrane TNF/soluble TNF receptor reverse signaling.
Autorzy :
Dykstra-Aiello C; Department of Integrative Physiology and Neuroscience, Washington State University-Spokane, WA, United States. Electronic address: .
Koh KMS; Department of Integrative Physiology and Neuroscience, Washington State University-Spokane, WA, United States.
Nguyen J; Department of Integrative Physiology and Neuroscience, Washington State University-Spokane, WA, United States.
Xue M; Department of Electrical Engineering, Washington State University-Pullman, WA, United States.
Roy S; Department of Electrical Engineering, Washington State University-Pullman, WA, United States.
Krueger JM; Department of Integrative Physiology and Neuroscience, Washington State University-Spokane, WA, United States.
Pokaż więcej
Źródło :
Brain, behavior, and immunity [Brain Behav Immun] 2021 May; Vol. 94, pp. 245-258. Date of Electronic Publication: 2021 Feb 09.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Receptors, Tumor Necrosis Factor, Type II*
Tumor Necrosis Factor-alpha*
Animals ; Female ; Male ; Mice ; Neuroglia ; Neurons ; Receptors, Tumor Necrosis Factor, Type I ; Signal Transduction
Czasopismo naukowe
Tytuł :
Mutations in the binding site of TNFR1 PLAD reduce homologous interactions but can enhance antagonism of wild-type TNFR1 activity.
Autorzy :
Albogami S; School of Life Sciences, University of Nottingham, Nottingham, UK.; Department of Biotechnology, School of Science, Taif University, Taif, Saudi Arabia.
Todd I; School of Life Sciences, University of Nottingham, Nottingham, UK.
Negm O; School of Life Sciences, University of Nottingham, Nottingham, UK.; Microbiology and Immunology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Fairclough LC; School of Life Sciences, University of Nottingham, Nottingham, UK.
Tighe PJ; School of Life Sciences, University of Nottingham, Nottingham, UK.
Pokaż więcej
Źródło :
Immunology [Immunology] 2021 Nov; Vol. 164 (3), pp. 637-654. Date of Electronic Publication: 2021 Aug 25.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Protein Domains/*genetics
Receptors, Tumor Necrosis Factor, Type I/*metabolism
Signal Transduction/*immunology
Binding Sites/genetics ; Cell Line, Tumor ; Humans ; Mutagenesis, Site-Directed ; Protein Multimerization/genetics ; Protein Multimerization/immunology ; Receptors, Tumor Necrosis Factor, Type I/genetics ; Tumor Necrosis Factor-alpha/metabolism
Czasopismo naukowe
Tytuł :
[Therapeutics for acute tubular necrosis in 2020].
Autorzy :
Lafargue MC; Service de néphrologie, hôpital Ambroise-Paré, AP-HP, 9, avenue Charles-de-Gaulle, 92100 Boulogne-Billancourt, France.
Aubert S; Service de néphrologie, hôpital Ambroise-Paré, AP-HP, 9, avenue Charles-de-Gaulle, 92100 Boulogne-Billancourt, France.
Rabemiarason N; Service de néphrologie, hôpital Ambroise-Paré, AP-HP, 9, avenue Charles-de-Gaulle, 92100 Boulogne-Billancourt, France.
Vilaine È; Service de néphrologie, hôpital Ambroise-Paré, AP-HP, 9, avenue Charles-de-Gaulle, 92100 Boulogne-Billancourt, France; Équipe 5, Inserm U-1018, UVSQ, université Paris Saclay, Villejuif, France.
Ebel A; Service de néphrologie, hôpital Ambroise-Paré, AP-HP, 9, avenue Charles-de-Gaulle, 92100 Boulogne-Billancourt, France.
Dargelos M; Service de néphrologie, hôpital Ambroise-Paré, AP-HP, 9, avenue Charles-de-Gaulle, 92100 Boulogne-Billancourt, France.
Couturier A; Service de néphrologie, hôpital Ambroise-Paré, AP-HP, 9, avenue Charles-de-Gaulle, 92100 Boulogne-Billancourt, France; Équipe 5, Inserm U-1018, UVSQ, université Paris Saclay, Villejuif, France.
Massy Z; Service de néphrologie, hôpital Ambroise-Paré, AP-HP, 9, avenue Charles-de-Gaulle, 92100 Boulogne-Billancourt, France; Équipe 5, Inserm U-1018, UVSQ, université Paris Saclay, Villejuif, France.
Essig M; Service de néphrologie, hôpital Ambroise-Paré, AP-HP, 9, avenue Charles-de-Gaulle, 92100 Boulogne-Billancourt, France; Équipe 5, Inserm U-1018, UVSQ, université Paris Saclay, Villejuif, France. Electronic address: .
Pokaż więcej
Transliterated Title :
Prise en charge de la nécrose tubulaire aiguë en 2020.
Źródło :
Nephrologie & therapeutique [Nephrol Ther] 2021 Apr; Vol. 17 (2), pp. 92-100. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :
Journal Article
MeSH Terms :
Acute Kidney Injury*/therapy
Kidney Tubular Necrosis, Acute*/etiology
Kidney Tubular Necrosis, Acute*/therapy
Endothelial Cells ; Humans ; Mitochondria ; Necrosis
Czasopismo naukowe
Tytuł :
Anti-TNF-α-induced lupus syndrome : Two case reports and review of current literature.
Autorzy :
Sieiro Santos C; Rheumatology Department, Complejo Asistencial Universitario de León, Calle Altos de nava, s/n, 24001, León, Spain. .
Álvarez Castro C; Rheumatology Department, Complejo Asistencial Universitario de León, Calle Altos de nava, s/n, 24001, León, Spain.
Moriano Morales C
Díez Álvarez E
Pokaż więcej
Transliterated Title :
Anti-TNF-α-induziertes Lupussyndrom : Übersicht über die aktuelle Literatur und 2 Kasuistiken.
Źródło :
Zeitschrift fur Rheumatologie [Z Rheumatol] 2021 Jun; Vol. 80 (5), pp. 481-486. Date of Electronic Publication: 2021 Mar 11.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Antirheumatic Agents*/adverse effects
Tumor Necrosis Factor Inhibitors*
Adalimumab ; Antibodies, Monoclonal ; Etanercept/adverse effects ; Humans ; Tumor Necrosis Factor-alpha
Czasopismo naukowe
Tytuł :
The Pancreatitis, Panniculitis, and Polyarthritis (PPP) Syndrome: Subcutaneous Nodular Fat Necrosis, a Cutaneous Marker of Pancreatic Neoplasia.
Autorzy :
Bernacka M; Małgorzata Bernacka, MD, Department of Dermatology and Venereology, Medical University of Lodz, , Plac J. Hallera 1/6, 90-647 Lodz, Poland; .
Kosztowny K
Schwartz RA
Hogendorf P
Bogaczewicz J
Woźniacka A
Pokaż więcej
Źródło :
Acta dermatovenerologica Croatica : ADC [Acta Dermatovenerol Croat] 2021 Apr; Vol. 291 (1), pp. 46-50.
Typ publikacji :
Case Reports
MeSH Terms :
Arthritis*/diagnosis
Arthritis*/etiology
Fat Necrosis*/complications
Fat Necrosis*/diagnosis
Pancreatic Neoplasms*/complications
Pancreatic Neoplasms*/diagnosis
Pancreatitis*/complications
Pancreatitis*/diagnosis
Panniculitis*/diagnosis
Panniculitis*/etiology
Humans ; Inflammation ; Male ; Middle Aged ; Necrosis
Raport
Tytuł :
Golimumab (anti-TNF monoclonal antibody): where we stand today.
Autorzy :
Melo AT; Rheumatology Department, Hospital De Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal.; Rheumatology Research Unit, Instituto De Medicina Molecular João Lobo Antunes, Faculdade De Medicina, Universidade De Lisboa, Lisbon, Portugal.
Campanilho-Marques R; Rheumatology Department, Hospital De Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal.; Rheumatology Research Unit, Instituto De Medicina Molecular João Lobo Antunes, Faculdade De Medicina, Universidade De Lisboa, Lisbon, Portugal.
Fonseca JE; Rheumatology Department, Hospital De Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon Academic Medical Centre, Lisbon, Portugal.; Rheumatology Research Unit, Instituto De Medicina Molecular João Lobo Antunes, Faculdade De Medicina, Universidade De Lisboa, Lisbon, Portugal.
Pokaż więcej
Źródło :
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Jun 03; Vol. 17 (6), pp. 1586-1598. Date of Electronic Publication: 2020 Dec 28.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Spondylitis, Ankylosing*
Tumor Necrosis Factor Inhibitors*
Antibodies, Monoclonal ; Humans ; Tumor Necrosis Factor-alpha
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies